WINTER SPRINGS, Fla., Oct. 08, 2021 (GLOBE NEWSWIRE) – IRadimed Corporation (NASDAQ: IRMD) today announced that the company will release its third quarter 2021 financial results before market opens on Friday, October 29.e. IRADIMED management will host a conference call the same day starting at 11:00 a.m. Eastern Time to discuss these results and answer questions.
Those interested in listening to the conference call can do so by dialing 1-844-413-1781 for domestic callers, or 1-716-247-5767 for international callers, and entering the reservation code 1675895.
The conference call will also be available in real time via the Internet at http://www.irameded.com/en-us/investors/events/. A recording of the call will be available on the Company’s website for 90 days after the call ends.
About IRADIMED CORPORATION
IRADIMED CORPORATION is a leader in the development of innovative medical devices compatible with Magnetic Resonance Imaging (“MRI”). We are the only known supplier of a non-magnetic intravenous (“IV”) infusion pump system specifically designed for safe use during MRI procedures. We were the first to develop an infusion delivery system that largely eliminates many dangers and problems present in MRI procedures. Standard infusion pumps contain magnetic and electronic components that can create radio frequency interference and are dangerous to use in the presence of the strong magnet that drives an MRI system. Our patented MRidium® MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor, uniquely designed non-ferrous parts and other special features to deliver anesthesia in a safe and predictable manner and other IV fluids during various MRI procedures. Our pump solution offers a seamless approach that enables precise, safe and reliable fluid delivery before, during and after an MRI, which is important for critically ill patients who cannot be removed from their life-saving medications, and for those with children and infants who usually need to be sedated to stay still during an MRI.
Our MRI 3880 compatible patient vital signs monitoring system has been designed with non-magnetic components and other special features to safely and accurately monitor a patient’s vital signs during various MRI procedures. The IRADIMED 3880 system operates reliably in magnetic fields up to 30,000 gauss, which means it can operate virtually anywhere in the MRI room. The IRADIMED 3880 has a compact and lightweight design allowing it to travel with the patient from their ICU, to MRI and back, improving patient safety through uninterrupted vital signs monitoring and reduces the time of absence of seriously ill patients. intensive care units. Features of the IRADIMED 3880 include: Wireless ECG with dynamic gradient filtering; Wireless SpO2 using Masimo® algorithms; Non-magnetic respiratory CO2; non-invasive blood pressure; the patient’s temperature, and; Optional advanced multigas anesthetic agent unit with continuous measurements of minimum alveolar concentration. The IRADIMED 3880 MRI Compatible Patient Vital Signs Monitoring System has an easy-to-use design and enables effective communication of patient vital signs information to clinicians.
Please visit www.iradimed.com for more information.
Financial and Operational Director